• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » John Cline Resigns from etrials

John Cline Resigns from etrials

May 21, 2007
CenterWatch Staff

Morrisville, N.C.-based eClinical company etrials reported that John Cline, founder and long time chief executive officer of the company, has resigned his post effective immediately in order to pursue other "entrepreneurial endeavors." He will, however, remain a member of the board of directors.

In 1999, Cline began the electronic paper diaries company Expidata, which was soon acquired by etrials (then PharmaCentric). The company -- along with most other eClinical companies in the space -- struggled through the early days of the electronic data capture marketplace.

As a thought leader in the clinical trials industry, Cline championed the value of paperless trials and helped usher in the modern EDC landscape we see today. In February 2006, etrials merged with CEA Acquisition Corp., a specified purpose acquisition company, changed its name to etrials Worldwide and began trading on the Nasdaq National Market. The merger gave the company a total of $20.5 million in cash.

"I am extremely proud and honored to have led our great employees from a small North Carolina start-up software firm to a top-tier, publicly-held global eClinical solutions company. As I move on to other entrepreneurial endeavors, I remain committed to etrials and support this change in management as a step forward in building a leading eClinical software solutions company," said Cline.

Last week ,etrials reported first quarter net services revenue jumped 51% to $4.1 million, compared with the same quarter a year ago. The company reported a loss of $0.9 million. In the first quarter of 2006, etrials reported a similar loss of $1 million. The company reported its gross margins improved to 47% compared with 40% the previous year.

It also reported a backlog of business of $19.8 million compared with $17.7 million at the end of 2006 and $24.8 million at the end of the first quarter of 2006. etrials reiterated that it expects new project bookings in 2007 will be up 40% to 50% over last year to $25 to $28 million.

“Our balance sheet remains strong, and we are well positioned to capitalize on the accelerating move towards electronic clinical software and services. We continue to believe 2007 will be a year of significant growth in new project bookings for etrials,” said Cline.

etrials has named Eugene "Chip" Jennings as the company's new president and CEO. Just prior to this position, Jennings was the senior corporate vice president of SHPS, a private healthcare management tools and resources company based in Kentucky.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing